Market Overview

Acne Treatment Market is projected to achieve a value of USD 11,109 Million in 2023, with a linear behavior in the market growth it is forecasted to achieve a value of USD 16,890 Million by 2033 with a CAGR of 5.6% during the forecast period 2023-2033.

Acne Treatment are related with the treatment of Skin. Acne is defining as a condition or disorder of skin that occur due to the blocked of hair follicle due to oil or dead skins. This condition mainly seen in teen agers, and continued in adulthoods, majorly in women’s. This is a type of skin disorder which affect any kind of skin whether it dry or oily skin respectively in any group of people or individual.

Acne Treatment which contain wide range of medications such as antibiotics, retinoid etc. Acne Treatment markets growth attributed by various factors such as rising prevalence of skin disease, abnormal hormonal changes in teens, increasing infrastructure investment, increasing new drug launches and product approvals, increasing research funding by key market players. Additionally, unhealthy urban life style and eating habit contributing to drive the market growth.

For instance, according to the National Center for Biotechnology Information (NCBI), in 2022, acne is the eighth most prevalent disease in the world which affected the 9.4% of the global population. Moreover, according to the American Academy of Dermatology Association, in US, acne is the most common skin condition, which affects 50 million Americans annually. Furthermore, as on July 2022, a new drugs launched by Glenmark Pharmaceuticals in the treatment of acne, under the brand name MINYM gel, in India. This is India’s first topical Minocycline 4% Gel to treat acne.

COVID 19 pandemic stumble the growth of Acne Treatment market due to world wild lockdown condition. Disturb in supply chain, reduction in number of patient seeking treatment, closing of dermatology clinics, decrease production staggered the growth of market. For instance, according to the study conduct by the American Association of Dermatology with dermatologists in the U.S., reported that an almost 43% decline in weekly patient consultations during the lockdown period compared to the pre-COVID-19 condition.

Market Scope

Market Dynamics

The Acne Treatment Market is driven by increasing prevalence of acne vulgaris. Additionally, abnormal hormonal imbalance, unhealthy food habit and sedentary life style, emerging level of social media and brand endorsement, novel drug development propel the growth of market. For instance, as per a publication in the Australian Journal of General Practice by the Royal Australian College of General Practitioners, it is widely observed that acne is prevalent in teenagers, affecting approximately 93.3% of individuals between the ages of 16 and 18 in Australia.

Moreover, the growing awareness of acne treatment among the population is fever to accept the growth of market in upcoming years. Additionally, factors like the proliferation of e-commerce platforms retailing acne related products, expanding internet access, and rapid urban growth are projected to drive up the demand for these products among the intended demographic, particularly in emerging economies. Social media plays a pivotal role as a major influencer in the market. The influence of social media on aesthetics has been substantial, particularly in shaping how consumers perceive and present themselves.

Furthermore, factors likes increasing awareness about current and new acne treatment, technological advancement, the growing desire for a more radiant and luminous skin complexion, the rising availability of products designed to regulate skin oil production and support pH balance has significantly will enhance the more growing opportunities in the market.

Despite the growing prevalence of acne worldwide, certain factors limit the growth of market. Side effect associated with drug treatment like nausea, dry skin, irritation. Moreover, oral drug treatment may causes upset of stomach, diarrhea. The U.S. Food and Drug Administration (FDA) issues warnings regarding specific over-the-counter (OTC) medications that may lead to potentially life-threatening allergic reactions or severe irritation upon usage.

Overall, with the help of existing and combination treatment therapy the Acne Treatment Market is expected to witness significant growth in the coming years, driven by the introduction of new therapies and an increasing demand for effective treatments. Additionally, there is a need for advance and effective research and development to address the unmet needs of acne treatment and to develop safe and effective therapies with lower side effects.

Market Product Analysis

By Product, the Acne Treatment Market is Categories into Retinoid, Antibiotics, Isotretinoin, and Others. The Antibiotics segment accounts for the largest share of around 37% in 2022.

The Antibiotics segment dominates the market the increasing approval of antibiotics for treating acne, coupled with their remarkable efficacy. Moreover, retinoid expected rapid growth in forecasted market due to the rising prevalence of moderate to severe acne problems and rise in retinoid demand.

Market Route of Administration Analysis

By Route of Administration, the Acne Treatment Market is Categories into Oral, Injectable and Topical. The Topical segment accounts for the largest share of around 33% in 2022.

The Topical segment dominates the market because the growing number of company’s manufacture topical solution for acne treatment because it is easily make available and comfortable to patient use.

Market Age Group Analysis

By Age Group, the Acne Treatment Market is Categories into 10 to 17 Years, 18 to 44 Years, 45 to 64 Years, and 65 Years & Above. The 18 to 44 Years segment accounts for the largest share of around 43% in 2022.

The 18 to 44 Years segment dominates the market because the increasing the number of patient population from this group, one of the main factors like abnormal hormonal changes during rising years.

Market Distribution Channel Analysis

By Distribution Channel, the Acne Treatment Market is Categories into Hospital Pharmacies, Retail stores, and Online Pharmacies. The retail segment accounts for the largest share of around 56% in 2022.

Retail stores segment dominate market due to the easy availability of medicine, OTC cream and ointments approval. However, Online pharmacies segment is growing in forecasted period due to the increasing popularity and convenience of medical purchasing.

Market Regional Analysis

North America dominate the Acne Treatment Market with the highest revenue generating market with share of more than 47%. The North America dominate this market due to the rising prevalence of skin problems in US, easy availability of medications, new products launch. Additionally, strong presence of market player, well developed infra structure, higher number of research favor growth of region.

Europe having the second-largest market share in Acne Treatment Market due to the rising demand for targeted medication, focus on R&D on Acne Treatment found in Europe. Moreover, favorable government policies in the region significantly contribute to expand the market.

Asia-Pacific is estimated the fastest growing CAGR in Acne Treatment Market in forecasted period. This is due to increasing in healthcare expenditure and the rise in research and development activities in the pharmaceutical sector.

Competitive Analysis

The Acne Treatment Market is dominated by a few large companies, such as Bausch Health Companies Inc., Galderma, Pfizer Inc., Almirall, Bayer AG, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Plc., Johnson & Johnson, Services, Inc, Skin Better Science, Revision Skincare, Glow Biotics LLC.

There are some of the recent developments of the Acne Treatment Market:

March 2022, Galderma unveiled its revolutionary skincare cream, Twyneo, designed to address moderate to severe facial acne, to the U.S. market during the American Academy of Dermatology (AAD) Annual Meeting.

January 2022, Galderma has announced that it has obtained antitrust clearance from U.S. authorities following the successful completion of its acquisition of ALASTIN Skincare, Inc. This acquisition is part of GALDERMA's efforts to develop innovative and clinically-tested physician-dispensed skincare products.

January 2021, GlaxoSmithKline plc has made an announcement regarding its agreement with Eligo BioScience to further the development of Eligobiotics, using CRISPR-based therapeutics to modulate strain-specific microbiomes for the treatment and prevention of Acne Vulgaris.

In June 2021, Almirall has revealed the launch of Seysara, a new oral antibiotic derived from tetracycline and notably the first one created specifically for the treatment of acne. This product is now available in the commercial market in the United States.

By Product Type

·         Retinoid

·         Antibiotics

·         Isotretinoin

·         Others

By Route of Administration Type

·         Oral

·         Injectable

·         Topical

By Age Group Type

·         10 to 17 Years

·         18 to 44 Years

·         45 to 64 Years

·         and 65 Years & Above

By Distribution Channel

·         Hospital Pharmacies

·         Retail stores

·         Online Pharmacies